Align Technology (ALGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $147.31, -1.36% vs the prior close of $149.34.
- Volume 952.96K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALGN dips 1.4% to $147.31. Closed at $147.31, -1.36% vs the prior close of $149.34. Day range $146.14β$152.26, opened at $150.37.
ALGN daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ALGN dips 1.4% to $147.31
- Closed at $147.31, -1.36% vs the prior close of $149.34. Day range $146.14β$152.26, opened at $150.37.
- Volume was 952.96K shares, 1.1x its 50-day average of 885.15K.
- Price is -4.5% vs its 50-day average ($154.31) and -13.1% vs its 200-day average ($169.51).
- 52-week range $128.65β$200.44; today's close sits at 26% of that range, 26.5% below the 52-week high.
Oct 15, 2026 β ALGN jumps 3.4% to $149.34, 3 up days in a row
- Closed at $149.34, +3.39% vs the prior close of $144.44. Day range $142.45β$149.78, opened at $143.92.
- Volume was 1.14M shares, 1.3x its 50-day average of 882.74K.
- Price is -3.5% vs its 50-day average ($154.75) and -11.9% vs its 200-day average ($169.57).
- 52-week range $127.72β$200.44; today's close sits at 30% of that range, 25.5% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 β ALGN rises 0.6% to $144.44
- Closed at $144.44, +0.63% vs the prior close of $143.54. Day range $141.86β$144.60, opened at $143.54.
- Volume was 718.40K shares, 0.8x its 50-day average of 890.69K.
- Price is -7.0% vs its 50-day average ($155.26) and -14.8% vs its 200-day average ($169.61).
- 52-week range $126.33β$200.44; today's close sits at 24% of that range, 27.9% below the 52-week high.
Oct 13, 2026 β ALGN rises 2.2% to $143.54
- Closed at $143.54, +2.22% vs the prior close of $140.42. Day range $139.81β$143.65, opened at $141.01.
- Volume was 997.90K shares, 1.1x its 50-day average of 890.71K.
- Price is -7.9% vs its 50-day average ($155.84) and -15.4% vs its 200-day average ($169.68).
- 52-week range $126.26β$200.44; today's close sits at 23% of that range, 28.4% below the 52-week high.
Oct 12, 2026 β ALGN dips 1.6% to $140.42
- Closed at $140.42, -1.60% vs the prior close of $142.71. Day range $140.33β$144.11, opened at $143.23.
- Volume was 849.80K shares, 0.9x its 50-day average of 905.88K.
- Price is -10.2% vs its 50-day average ($156.42) and -17.3% vs its 200-day average ($169.75).
- 52-week range $124.91β$200.44; today's close sits at 21% of that range, 29.9% below the 52-week high.
Oct 9, 2026 β ALGN rises 1.2% to $142.71
- Closed at $142.71, +1.19% vs the prior close of $141.03. Day range $140.10β$142.86, opened at $141.00.
- Volume was 1.08M shares, 1.2x its 50-day average of 914.98K.
- Price is -9.1% vs its 50-day average ($157.00) and -16.0% vs its 200-day average ($169.83).
- 52-week range $124.91β$200.44; today's close sits at 24% of that range, 28.8% below the 52-week high.
Oct 8, 2026 β ALGN rises 0.8% to $141.03
- Closed at $141.03, +0.83% vs the prior close of $139.87. Day range $138.05β$141.12, opened at $138.59.
- Volume was 1.34M shares, 1.5x its 50-day average of 921.24K.
- Price is -10.5% vs its 50-day average ($157.61) and -17.0% vs its 200-day average ($169.91).
- 52-week range $124.91β$200.44; today's close sits at 21% of that range, 29.6% below the 52-week high.
Oct 7, 2026 β ALGN dips 1.1% to $139.87, a 6-month low
- Closed at $139.87, -1.12% vs the prior close of $141.45. Day range $138.95β$141.00, opened at $140.46.
- Volume was 678.80K shares, 0.7x its 50-day average of 925.94K.
- Price is -11.7% vs its 50-day average ($158.39) and -17.7% vs its 200-day average ($170.00).
- 52-week range $124.91β$200.44; today's close sits at 20% of that range, 30.2% below the 52-week high.
Oct 6, 2026 β ALGN rises 0.6% to $141.45
- Closed at $141.45, +0.57% vs the prior close of $140.65. Day range $141.14β$143.64, opened at $141.96.
- Volume was 1.02M shares, 1.1x its 50-day average of 926.19K.
- Price is -11.1% vs its 50-day average ($159.11) and -16.8% vs its 200-day average ($170.10).
- 52-week range $124.91β$200.44; today's close sits at 22% of that range, 29.4% below the 52-week high.
Oct 5, 2026 β ALGN dips 2.1% to $140.65, a 6-month low on 1.8x normal volume
- Closed at $140.65, -2.15% vs the prior close of $143.74. Day range $138.36β$142.35, opened at $140.07.
- Volume was 1.68M shares, 1.8x its 50-day average of 909.51K β unusually heavy trading.
- Price is -11.9% vs its 50-day average ($159.64) and -17.4% vs its 200-day average ($170.20).
- 52-week range $124.91β$200.44; today's close sits at 21% of that range, 29.8% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 β ALGN dips 1.1% to $143.74, a 6-month low
- Closed at $143.74, -1.11% vs the prior close of $145.35. Day range $143.23β$147.09, opened at $147.09.
- Volume was 550.00K shares, 0.6x its 50-day average of 914.93K.
- Price is -10.3% vs its 50-day average ($160.17) and -15.6% vs its 200-day average ($170.31).
- 52-week range $124.91β$200.44; today's close sits at 25% of that range, 28.3% below the 52-week high.
ALGN latest news & SEC filings
Every SEC filing by or about ALGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 31, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 31, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Aug 12, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.06B (prior year $1.01B) (+4.3% vs Jun 30, 2025)
- Net income: $108.29M (prior year $124.61M) (-13.1% vs Jun 30, 2025)
- Diluted EPS: $1.51 (prior year $1.72) (-12.2% vs Jun 30, 2025)
Jul 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 9, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Jun 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade ALGN
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 4, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.48% (largest 4.4%).
- Liquidity: about 962.77K shares (β$141.83M) trade per day on average.
- 52-week position: $147.31 vs a range of $128.65β$200.44 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: John Morici sold 7,969 shares on Feb 18, 2026.
- Latest filings: 8-K Aug 31, 2026; 10-Q Aug 5, 2026; 8-K Jul 29, 2026.
- Share count: 71.04M shares outstanding (Jul 31, 2026), -2.0% vs a year earlier.
- Listing: Nasdaq Β· industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
ALGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 150.37 | 152.26 | 146.14 | 147.31 | 952.96K |
| Oct 15, 2026 | 143.92 | 149.78 | 142.45 | 149.34 | 1.14M |
| Oct 14, 2026 | 143.54 | 144.60 | 141.86 | 144.44 | 718.40K |
| Oct 13, 2026 | 141.01 | 143.65 | 139.81 | 143.54 | 997.90K |
| Oct 12, 2026 | 143.23 | 144.11 | 140.33 | 140.42 | 849.80K |
| Oct 9, 2026 | 141.00 | 142.86 | 140.10 | 142.71 | 1.08M |
| Oct 8, 2026 | 138.59 | 141.12 | 138.05 | 141.03 | 1.34M |
| Oct 7, 2026 | 140.46 | 141.00 | 138.95 | 139.87 | 678.80K |
| Oct 6, 2026 | 141.96 | 143.64 | 141.14 | 141.45 | 1.02M |
| Oct 5, 2026 | 140.07 | 142.35 | 138.36 | 140.65 | 1.68M |
| Oct 2, 2026 | 147.09 | 147.09 | 143.23 | 143.74 | 550.00K |
| Oct 1, 2026 | 145.00 | 146.23 | 143.23 | 145.35 | 619.80K |
| Sep 30, 2026 | 144.61 | 146.68 | 142.83 | 145.35 | 917.80K |
| Sep 29, 2026 | 145.00 | 145.93 | 142.24 | 144.01 | 937.30K |
| Sep 28, 2026 | 145.00 | 146.20 | 143.33 | 145.00 | 882.80K |
| Sep 25, 2026 | 145.57 | 148.17 | 144.20 | 146.78 | 829.60K |
| Sep 24, 2026 | 148.65 | 149.22 | 145.27 | 145.63 | 785.80K |
| Sep 23, 2026 | 152.50 | 153.40 | 147.07 | 148.17 | 1.33M |
| Sep 22, 2026 | 149.17 | 154.10 | 147.62 | 153.29 | 966.90K |
| Sep 21, 2026 | 147.97 | 148.37 | 145.55 | 146.88 | 975.80K |
About Align Technology
Align Technology (ALGN) is listed on the Nasdaq and classified by the SEC under βOrthopedic, Prosthetic & Surgical Appliances & Suppliesβ. Its business address is in TEMPE, AZ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1097149.
ALGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Quentin S. Blackford | Director | Aug 31, 2026 |
| Kevin T Conroy | Director | May 22, 2026 |
| Kevin J Dallas | Director | May 22, 2026 |
| Joseph M Hogan | President and CEO | Feb 24, 2026 |
| Joseph Lacob | Director | May 22, 2026 |
| C Raymond Jr Larkin | Director | May 22, 2026 |
| George J Morrow | Director | May 22, 2026 |
| Anne Myong | Director | May 22, 2026 |
| Mojdeh Poul | Director | May 22, 2026 |
| Susan E Siegel | Director | May 22, 2026 |
| Andrea Lynn Saia | Director | May 22, 2026 |
| Britt J. Vitalone | Director | May 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Julie Ann Coletti | EVP, CHIEF LEGAL & REGULATORY | Feb 24, 2026 |
| Joseph M Hogan | President and CEO | Feb 24, 2026 |
| Stuart A Hockridge | EVP, GLOBAL HR | Feb 24, 2026 |
| Jitse Marree | See Remarks | May 11, 2026 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER | Feb 24, 2026 |
| Jaime Holte Richardson | See Remarks | Apr 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 18, 2026 | John Morici | Sale | 7,969 | $189.31 |
| Feb 18, 2026 | John Morici | Sale | 7,969 | $189.31 |
| Feb 18, 2026 | John Morici | Sale | 7,969 | $189.31 |
| Feb 18, 2026 | John Morici | Sale | 7,969 | $189.31 |
ALGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $4.03B | $410.35M | 5.65 | $593.22M |
| Dec 31, 2024 | $4.00B | $421.36M | 5.62 | $738.23M |
| Dec 31, 2023 | $3.86B | $445.05M | 5.81 | $785.78M |
| Dec 31, 2022 | $3.73B | $361.57M | 4.61 | $568.73M |
| Dec 31, 2021 | $3.95B | $772.02M | 9.69 | $1.17B |
Latest balance sheet: total assets $6.42B, total liabilities $2.19B, cash $1.10B (as of Jun 30, 2026).
ALGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $180.08 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $178.40 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $161.30 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $131.91 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $203.57 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $173.30 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $216.36 |
| Oct 23, 2024 | 8-K Item 2.02 (results) | $207.66 |
| Jul 24, 2024 | 8-K Item 2.02 (results) | β |
| Apr 24, 2024 | 8-K Item 2.02 (results) | β |
| Jan 31, 2024 | 8-K Item 2.02 (results) | β |
| Oct 25, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)Anteris Technologies Global (AVR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.